Table 3 Adjusteda excess hazard ratios (EHR) of death within 5 years of diagnosis, with 95% confidence intervals (CI): colorectal cancer patients in AXIS trial
From: No socioeconomic inequalities in colorectal cancer survival within a randomised clinical trial
EHR | 95% CI | P -value | |
---|---|---|---|
Deprivation | |||
Most affluent | 1.00 | 0.54 | |
2 | 1.17 | (0.92–1.51) | |
3 | 1.09 | (0.84–1.42) | |
4 | 1.18 | (0.91–1.52) | |
Most deprived | 1.20 | (0.92–1.57) | |
Age at randomisation | |||
10-year difference | 1.07 | (1.05–1.10) | 0.06 |
Duke's stage | |||
A | 1.00 | <0.001 | |
B | 4.57 | (1.82–11.46) | |
C | 14.36 | (5.76–35.78) | |
D | 65.83 | (26.11–165.96) | |
Tumour site | |||
Colon | 1.00 | <0.001 | |
Rectum | 1.33 | (1.14–1.55) | |
Sex | |||
Male | 1.00 | 0.10 | |
Female | 0.89 | (0.76–1.06) |